IPG PHOTONICS CORP annual report, FY2014

Business context and reporting period

IPG Photonics Corporation develops and manufactures fiber lasers, amplifiers, diode lasers and related systems. Its products serve materials processing and other markets; the company operates globally and manufactures key components in-house. This Form 10-K covers the fiscal year ended December 31, 2014. Fourth-quarter figures are unaudited.

Financial performance and liquidity

MetricFY 2014FY 2013
Revenue$769.8 million$648.0 million
Gross profit / margin$416.5 million / 54.1%$339.9 million / 52.5%
Operating income / margin$283.8 million / 36.9%$218.1 million / 33.7%
Net income$200.4 million$155.8 million
Diluted EPS$3.79$2.97
Cash from operations$180.1 million$119.4 million
Capital expenditures$88.6 million$70.9 million

Fourth-quarter 2014 revenue was $207.4 million and net income was $56.4 million, compared with $165.9 million and $36.6 million, respectively, in fourth-quarter 2013. Year-end cash and cash equivalents were $522.2 million; working capital excluding cash was $249.6 million. Total debt, including revolving borrowings, was approximately $35.6 million. The company reported $66.9 million of unused credit facilities and compliance with its financial covenants.

Material changes versus prior comparable period

  • Annual revenue rose 18.8%; materials-processing sales increased 20.1% to $731.3 million and represented 95% of sales. Growth came principally from high- and mid-power and QCW lasers for cutting, welding and sintering.
  • Gross margin improved 1.6 percentage points, reflecting product mix, lower component costs relative to selling-price declines, and lower excess-inventory provisions.
  • Net income increased 28.7%. Operating expenses rose, notably R&D, which increased 28.2% to $53.4 million; R&D was 6.9% of revenue.
  • Cash from operations improved, although receivables increased by $48.5 million and inventory by $42.2 million, using cash. Cash also benefited from increased net income and changes in taxes payable.
  • China generated $245.1 million, or 31.9%, of sales, up from $192.1 million in 2013. The largest customer represented 11% of sales in both years; the five largest represented 23% in 2014.

Outlook, management commentary, risks and unusual items

Management expects capital expenditures of approximately $60 million to $65 million in 2015, excluding acquisitions, to expand and upgrade capacity. It expects to ship a substantial majority of the $321.0 million year-end backlog during 2015, but notes that orders—particularly frame agreements—may be canceled or delayed and backlog is not necessarily predictive of sales. The filing provides no specific revenue or earnings guidance. Management expects continued investment in R&D, sales and marketing, and administrative resources.

  • Key exposures include cyclical customer capital spending, especially in materials processing; competitive pricing and declining average selling prices; reliance on China and a limited number of customers; foreign-exchange movements; and high fixed costs, manufacturing capacity and inventory.
  • Russia-related sanctions had not materially disrupted operations by the filing date, but further sanctions or supply interruptions could affect production and deliveries. China accounted for about 32% of sales.
  • Currency translation produced a $110.7 million loss in other comprehensive income in 2014, substantially increasing accumulated other comprehensive loss. Separately, the company recorded a $6.6 million foreign-exchange gain in operating expenses.
  • Inventory provisions were $11.3 million, down from $15.1 million in 2013. A $22.0 million aircraft purchase was financed with debt; the related note had a $21.7 million balance at year-end.
  • The company reported no ongoing legal proceedings it expected to have a material financial-statement effect. A former consultant’s trade-secret lawsuit was voluntarily dismissed in August 2014. Deloitte issued unqualified opinions on the financial statements and internal controls.

Important facts for investors to verify

  1. Whether materials-processing demand, particularly in China, and the year-end backlog convert into shipments and revenue in 2015.
  2. Whether gross-margin gains persist amid price declines, competition, product mix changes and inventory provisions.
  3. Whether working-capital growth, especially receivables and inventory, affects operating cash generation.
  4. Whether Russia-related sanctions, currency movements or supply disruptions affect manufacturing, deliveries or reported results.
  5. The status and terms of the U.S. credit facility due to expire in June 2015 and repayment of the $11.3 million U.S. note due that month.